European Journal of Cancer
Volume 45, Issue 10 , Pages 1831-1838 , July 2009

Metabolic syndrome and risk of cancer mortality in men

  • Jason R. Jaggers

      Affiliations

    • Department of Exercise Science, Arnold School of Public Health, University of South Carolina, 921 Assembly Street, Columbia, SC 29208, United States
    • Corresponding Author InformationCorresponding author: Tel.: +1 803 777 8421; fax: +1 803 708 5567.
    • ,
  • Xuemei Sui

      Affiliations

    • Department of Exercise Science, Arnold School of Public Health, University of South Carolina, 921 Assembly Street, Columbia, SC 29208, United States
    • ,
  • Steven P. Hooker

      Affiliations

    • Department of Exercise Science, Arnold School of Public Health, University of South Carolina, 921 Assembly Street, Columbia, SC 29208, United States
    • ,
  • Michael J. LaMonte

      Affiliations

    • Department of Social and Preventive Medicine, University of Buffalo, Buffalo, NY, United States
    • ,
  • Charles E. Matthews

      Affiliations

    • Vanderbilt University Medical Center, Institute for Medicine and Public Health, Vanderbilt-Ingram Cancer Center, Nashville, TN, United States
    • ,
  • Gregory A. Hand

      Affiliations

    • Department of Exercise Science, Arnold School of Public Health, University of South Carolina, 921 Assembly Street, Columbia, SC 29208, United States
    • ,
  • Steven N. Blair

      Affiliations

    • Department of Exercise Science, Arnold School of Public Health, University of South Carolina, 921 Assembly Street, Columbia, SC 29208, United States
    • Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States

Received 14 September 2008 ,Revised 22 January 2009 ,Accepted 28 January 2009.

References 

  1. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer?. Am J Pathol. 2006;169(5):1505–1522
  2. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005;56:45–62
  3. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27(10):2444–2449
  4. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86(3):s836–s842
  5. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Circulation. 2004;109(3):433–438
  6. Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med. 2004;164(10):1092–1097
  7. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10(1):15–32
  8. Hsing AW, Gao YT, Chua S, Deng J, Stanczyk FZ. Insulin resistance and prostate cancer risk. J Natl Cancer Inst. 2003;95(1):67–71
  9. La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer. 1994;70(5):950–953
  10. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–422
  11. Thygesen LC, Gronbaek M, Johansen C, et al. Prospective weight change and colon cancer risk in male US health professionals. Int J Cancer. 2008;123(5):1160–1165
  12. Trevisan M, Liu J, Muti P, et al. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev. 2001;10(9):937–941
  13. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. Jama. 2005;293(2):194–202
  14. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11(4):385–391
  15. Blair SN, Kampert JB, Kohl HW, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. Jama. 1996;276(3):205–210
  16. Blair SN, Kohl HW, Paffenbarger RS, et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. Jama. 1989;262(17):2395–2401
  17. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Hypertension. 2005;45(1):142–161
  18. Balke B, Ware RW. An experimental study of physical fitness of air force personnel. US Armed Forces Med J. 1959;10(6):675–688
  19. Pollock ML, Bohannon RL, Cooper KH, et al. A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J. 1976;92(1):39–46
  20. American College of Sports Medicine . ACSM’s guidelines for exercise testing and prescription. 7th ed.. Philadelphia: Lippincott Williams and Wilkins; 2005;
  21. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112(17):2735–2752
  22. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006;107(1):28–36
  23. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2391–2397
  24. LaMonte MJ, Barlow CE, Jurca R, et al. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women. Circulation. 2005;112(4):505–512
  25. Hsing AW, Sakoda LC, Chua S. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86(3):s843–s857
  26. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–1638
  27. Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer. 2003;104(6):669–676
  28. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2004;111(5):762–771
  29. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131(11 Suppl):3109S–3120S
  30. Koohestani N, Tran TT, Lee W, Wolever TM, Bruce WR. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet. Nutr Cancer. 1997;29(1):69–76
  31. Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002;63(4):317–332

PII: S0959-8049(09)00057-4

doi: 10.1016/j.ejca.2009.01.031

European Journal of Cancer
Volume 45, Issue 10 , Pages 1831-1838 , July 2009

Article Tools

* Image Usage & Resolution